Correlation Between Ikena Oncology and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Pliant Therapeutics, you can compare the effects of market volatilities on Ikena Oncology and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Pliant Therapeutics.
Diversification Opportunities for Ikena Oncology and Pliant Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ikena and Pliant is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Ikena Oncology and Pliant Therapeutics
Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.12 times more return on investment than Pliant Therapeutics. However, Ikena Oncology is 8.28 times less risky than Pliant Therapeutics. It trades about -0.19 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 152.00 in Ikena Oncology on November 28, 2024 and sell it today you would lose (12.50) from holding Ikena Oncology or give up 8.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. Pliant Therapeutics
Performance |
| Timeline |
| Ikena Oncology |
| Pliant Therapeutics |
Ikena Oncology and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Pliant Therapeutics
The main advantage of trading using opposite Ikena Oncology and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |